A late-stage clinical biopharmaceutical company focused on developing non-opioid pain management products for acute and chronic pain treatment, with its lead candidate SP-102 in Phase 3 clinical trials for lumbosacral radicular pain.
Palo Alto, CA, United States~10 employeesFounded Jan 2013Website
BiotechnologyPharmaceuticalsPain ManagementNon-OpioidClinical Development